EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Heme-Binding Groups in Cytochrome P450 Inhibitors: Coordination Mechanisms, Evidence Standards and Implications for CYP19A1 Ligand Design

Paweł Kozyra iD, Maciej Masłyk iD

Molecules · 2026

DOI: 10.3390/molecules31203656 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, 2026. Verfasst von Paweł Kozyra und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Analytical Chemistry, The John Paul II Catholic University of Lublin, St. Konstantynów 1j, 20-708 Lublin, Poland. Hauptthemen laut MEDLINE: Heme, Cytochrome P-450 Enzyme Inhibitors, Aromatase. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cytochrome P450 (CYP) enzymes are heme-thiolate monooxygenases whose inhibition can result from direct reversible axial ligation of the distal heme iron, perturbation of the axial-water environment, or metabolism-dependent heme interactions. This focused review critically examines the chemical classes used as putative heme-binding groups in small-molecule CYP inhibitors, with emphasis on imidazoles, 1,2,4-triazoles, pyridines, 1,2,3-triazoles, sulfur-containing heterocycles, hydroxamates, nitriles and isonitriles. We discuss the evidential limits of ligand-induced type II spectra, distinguish direct parent–ligand coordination from mechanism-based inactivation, and outline an evidence hierarchy integrating enzymology, UV–Vis spectroscopy, EPR-based methods, structural biology and QM/MM calculations. CYP19A1 is used as a medicinal-chemistry case study illustrating how donor identity, binding geometry, scaffold recognition and selectivity against drug-metabolising and steroidogenic CYP enzymes must be optimized concurrently. We propose practical design and validation principles for the development of selectively heme-directed CYP19A1 inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HemeCytochrome P-450 Enzyme InhibitorsAromataseLigandsHumansCytochrome P-450 Enzyme SystemDrug DesignModels, MolecularProtein BindingImidazoles

Stichwörter der Autor:innen

CYP19A1aromatasearomatase inhibitorschelationcoordination mechanismscytochrome P450drug discoveryhemeheme-binding groups

Substanzen

HemeLigandsCytochrome P-450 Enzyme InhibitorsAromataseCytochrome P-450 Enzyme SystemCYP19A1 protein, humanImidazoles

Autor:innen und Institutionen

  • Department of Biomedical and Analytical Chemistry, The John Paul II Catholic University of Lublin, St. Konstantynów 1j, 20-708 Lublin, Poland.
  • AI Drug Discovery Center, The John Paul II Catholic University of Lublin, St. Konstantynów 1j, 20-708 Lublin, Poland.
  • Department of Molecular Biology, The John Paul II Catholic University of Lublin, ul. Konstantynów 1i, 20-708 Lublin, Poland.

ORCID-Profile: Paweł Kozyra, Maciej Masłyk

Zitieren

APA

Kozyra, P., & Masłyk, M. (2026). Heme-Binding Groups in Cytochrome P450 Inhibitors: Coordination Mechanisms, Evidence Standards and Implications for CYP19A1 Ligand Design. Molecules. https://doi.org/10.3390/molecules31203656

Vancouver

Kozyra P, Masłyk M. Heme-Binding Groups in Cytochrome P450 Inhibitors: Coordination Mechanisms, Evidence Standards and Implications for CYP19A1 Ligand Design. Molecules. 2026. doi:10.3390/molecules31203656

BibTeX
@article{Kozyra2026,
  author = {Kozyra, Paweł and Masłyk, Maciej},
  title = {Heme-Binding Groups in Cytochrome P450 Inhibitors: Coordination Mechanisms, Evidence Standards and Implications for CYP19A1 Ligand Design},
  journal = {Molecules},
  year = {2026},
  doi = {10.3390/molecules31203656}
}
Kostenlos starten →